Durability of Early Combination Therapy vs Conventional Therapy in New Onset T2DM

Defronzo, Ralph A (PI)

Medicine

Project: Research project

Project Details

Description

? DESCRIPTION (provided by applicant): Hyperglycemia is the major risk factor for the development of diabetic microvascular complications. The ADA recommends lowering the A1c in T2DM individuals to levels (i.e. HbA1c

Status	Finished
Effective start/end date	9/1/15 → 8/31/18

Funding

National Institutes of Health: $479,984.00

View all

View less

ASJC

Medicine(all)

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.